Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice

Stephen Kennel, Sally Macy, Craig Wooliver, Ying Huang, Tina Richey, Robert Heidel, Jonathan Wall

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: Determine the role of phagocytosis in the deposition of acute phase SAA protein in peripheral organs as AA amyloid. Methods: AA amyloidosis was induced by injection of amyloid enhancing factor (AEF) in huIL-6 transgenic mice. Clodronate liposomes were injected at different times, and the amyloid load evaluated by Congo red birefringence staining and monitoring with the amyloid specific probe 125I-labeled peptide p5R. Results: Injection of clodronate containing liposomes depleted Iba-1 positive and F4/80 positive phagocytic cells in liver and spleen for up to 5 days. Treatment prior to administration of intravenous AEF did not alter the pattern of deposition of the AEF in spleen, but inhibited the catabolism of the 125I-labeled AEF. Clodronate treatment 1 day before or 1 day after AEF administration had little effect on AA amyloid accumulation at 2 weeks; however, mice treated with clodronate liposomes 5 days after AEF induction and evaluated at 2 weeks post-AEF induction showed reduced amyloid load relative to controls. At 6 weeks post-AEF there was no significant effect on amyloid load following a single clodronate treatment. Conclusion: Macrophages have been shown to be instrumental in both accumulation and clearance of AA amyloid after cessation of inflammation. Our data indicate that when SAA protein is continuously present, depletion of phagocytic cells during the early course of the disease progression temporarily reduces amyloid load.

Original languageEnglish (US)
Pages (from-to)45-53
Number of pages9
JournalAmyloid
Volume21
Issue number1
DOIs
StatePublished - Mar 1 2014
Externally publishedYes

Fingerprint

Phagocytes
Amyloid
Transgenic Mice
Clodronic Acid
Liposomes
Spleen
Birefringence
Congo Red
Injections
amyloid enhancing factor
Acute-Phase Proteins
Amyloidosis
Phagocytosis
Intravenous Administration
Disease Progression
Therapeutics
Macrophages
Staining and Labeling
Inflammation
Peptides

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice. / Kennel, Stephen; Macy, Sally; Wooliver, Craig; Huang, Ying; Richey, Tina; Heidel, Robert; Wall, Jonathan.

In: Amyloid, Vol. 21, No. 1, 01.03.2014, p. 45-53.

Research output: Contribution to journalArticle

Kennel, Stephen ; Macy, Sally ; Wooliver, Craig ; Huang, Ying ; Richey, Tina ; Heidel, Robert ; Wall, Jonathan. / Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice. In: Amyloid. 2014 ; Vol. 21, No. 1. pp. 45-53.
@article{a49063a91d2943409deb3bcec849547b,
title = "Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice",
abstract = "Objective: Determine the role of phagocytosis in the deposition of acute phase SAA protein in peripheral organs as AA amyloid. Methods: AA amyloidosis was induced by injection of amyloid enhancing factor (AEF) in huIL-6 transgenic mice. Clodronate liposomes were injected at different times, and the amyloid load evaluated by Congo red birefringence staining and monitoring with the amyloid specific probe 125I-labeled peptide p5R. Results: Injection of clodronate containing liposomes depleted Iba-1 positive and F4/80 positive phagocytic cells in liver and spleen for up to 5 days. Treatment prior to administration of intravenous AEF did not alter the pattern of deposition of the AEF in spleen, but inhibited the catabolism of the 125I-labeled AEF. Clodronate treatment 1 day before or 1 day after AEF administration had little effect on AA amyloid accumulation at 2 weeks; however, mice treated with clodronate liposomes 5 days after AEF induction and evaluated at 2 weeks post-AEF induction showed reduced amyloid load relative to controls. At 6 weeks post-AEF there was no significant effect on amyloid load following a single clodronate treatment. Conclusion: Macrophages have been shown to be instrumental in both accumulation and clearance of AA amyloid after cessation of inflammation. Our data indicate that when SAA protein is continuously present, depletion of phagocytic cells during the early course of the disease progression temporarily reduces amyloid load.",
author = "Stephen Kennel and Sally Macy and Craig Wooliver and Ying Huang and Tina Richey and Robert Heidel and Jonathan Wall",
year = "2014",
month = "3",
day = "1",
doi = "10.3109/13506129.2013.876400",
language = "English (US)",
volume = "21",
pages = "45--53",
journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",
issn = "1350-6129",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice

AU - Kennel, Stephen

AU - Macy, Sally

AU - Wooliver, Craig

AU - Huang, Ying

AU - Richey, Tina

AU - Heidel, Robert

AU - Wall, Jonathan

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Objective: Determine the role of phagocytosis in the deposition of acute phase SAA protein in peripheral organs as AA amyloid. Methods: AA amyloidosis was induced by injection of amyloid enhancing factor (AEF) in huIL-6 transgenic mice. Clodronate liposomes were injected at different times, and the amyloid load evaluated by Congo red birefringence staining and monitoring with the amyloid specific probe 125I-labeled peptide p5R. Results: Injection of clodronate containing liposomes depleted Iba-1 positive and F4/80 positive phagocytic cells in liver and spleen for up to 5 days. Treatment prior to administration of intravenous AEF did not alter the pattern of deposition of the AEF in spleen, but inhibited the catabolism of the 125I-labeled AEF. Clodronate treatment 1 day before or 1 day after AEF administration had little effect on AA amyloid accumulation at 2 weeks; however, mice treated with clodronate liposomes 5 days after AEF induction and evaluated at 2 weeks post-AEF induction showed reduced amyloid load relative to controls. At 6 weeks post-AEF there was no significant effect on amyloid load following a single clodronate treatment. Conclusion: Macrophages have been shown to be instrumental in both accumulation and clearance of AA amyloid after cessation of inflammation. Our data indicate that when SAA protein is continuously present, depletion of phagocytic cells during the early course of the disease progression temporarily reduces amyloid load.

AB - Objective: Determine the role of phagocytosis in the deposition of acute phase SAA protein in peripheral organs as AA amyloid. Methods: AA amyloidosis was induced by injection of amyloid enhancing factor (AEF) in huIL-6 transgenic mice. Clodronate liposomes were injected at different times, and the amyloid load evaluated by Congo red birefringence staining and monitoring with the amyloid specific probe 125I-labeled peptide p5R. Results: Injection of clodronate containing liposomes depleted Iba-1 positive and F4/80 positive phagocytic cells in liver and spleen for up to 5 days. Treatment prior to administration of intravenous AEF did not alter the pattern of deposition of the AEF in spleen, but inhibited the catabolism of the 125I-labeled AEF. Clodronate treatment 1 day before or 1 day after AEF administration had little effect on AA amyloid accumulation at 2 weeks; however, mice treated with clodronate liposomes 5 days after AEF induction and evaluated at 2 weeks post-AEF induction showed reduced amyloid load relative to controls. At 6 weeks post-AEF there was no significant effect on amyloid load following a single clodronate treatment. Conclusion: Macrophages have been shown to be instrumental in both accumulation and clearance of AA amyloid after cessation of inflammation. Our data indicate that when SAA protein is continuously present, depletion of phagocytic cells during the early course of the disease progression temporarily reduces amyloid load.

UR - http://www.scopus.com/inward/record.url?scp=84896698070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896698070&partnerID=8YFLogxK

U2 - 10.3109/13506129.2013.876400

DO - 10.3109/13506129.2013.876400

M3 - Article

VL - 21

SP - 45

EP - 53

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

SN - 1350-6129

IS - 1

ER -